All PlansPrior AuthHigh impact
Spinal Cord and Dorsal Root Ganglion Stimulation
Regence BlueShield·Neurosurgery, Pain Management, Cardiology +1 more·Medical Policy
Effective date
Jul 1, 2026
We identified it
Jul 7, 2026
Summary
This is a new medical policy effective July 1, 2026, establishing coverage criteria for spinal cord stimulation (standard, high-frequency) and dorsal root ganglion stimulation procedures. The policy requires strict pre-authorization documentation including 6+ months of failed conservative therapy, psychiatric/behavioral health clearance, and a 50% pain reduction threshold during trial periods before permanent implantation. Billing teams must implement documentation requirements and prior authorization processes immediately to prevent claim denials.
Action Required
By June 1, 2026: Billing and clinical teams must implement the following procedures: (1) Establish prior authorization workflow requiring documentation of 6+ months conservative therapy failure, psychiatric clearance attestation, and clinical notes supporting medical necessity before approving trial procedures; (2) Update encounter forms and EMR templates to include required documentation fields for all four indications (failed back surgery syndrome, complex regional pain syndrome, chronic critical limb ischemia, chronic stable angina); (3) Create authorization hold rules in billing system requiring 50% pain reduction documentation from provider before processing permanent implantation claims; (4) Train billing staff to verify psychiatric/behavioral health provider attestation is from qualified professionals (licensed psychologist, psychiatrist, LCSW/LICSW, licensed masters counselor, or PMHNP); (5) Establish tracking system for trial-to-permanent conversion authorizations; (6) Develop denial letter templates for claims missing required documentation. Failure to obtain complete documentation and prior authorization will result in claim denials, as contract language takes precedence over policy language.